Search
Search
As bioprocesses scale from development to manufacturing, filtration challenges can arise across the workflow as a result of evolving process conditions, tightening impurity tolerances, and increasing performance expectations. Bioprocess filtration should be evaluated at each stage based on process objectives, upstream conditions, and downstream processing (DSP) requirements.
Early stages focus on managing cells, debris, and solids load during harvest and clarification. As processes advance and regulatory scrutiny increases, emphasis shifts to controlling residual impurities and bioburden while maintaining operating consistency and system integration to support scalable manufacturing. At Thermo Fisher Scientific, bioprocess filtration solutions are designed to align with these requirements across process development and production.
Filtration is used effectively when evaluated as part of the broader bioprocessing workflow, where decisions made upstream influence downstream performance. Considering filtration in relation to upstream conditions and downstream requirements helps inform the technology, configuration, staging, and assessment of unit operations during process development and scale-up. We support this evaluation by aligning filtration solutions with overall process design and scale-up planning.
Filtration requirements vary by modality, process design, and development stage. Differences in feedstream composition, impurity profiles, and downstream process requirements influence how filtration is evaluated and applied.
As demand for monoclonal antibodies (mAbs) continues to grow, teams face increasing pressure to achieve higher productivity, consistent quality, and scalable processes. Filtration is applied across monoclonal antibody and recombinant protein workflows to support harvest, clarification, and downstream conditioning, using technologies, such as Harvest RC Chromatographic Clarifier platform, Zeta Plus depth filters, Emphaze AEX Hybrid Purifier, and Polisher ST Membrane Adsorber, as part of integrated upstream and downstream strategies.
Thermo Fisher offers mAb bioprocessing solutions across the full workflow, incorporating filtration alongside cell culture, centrifugation, chromatography, and process liquid management to help evaluate, optimize, and scale processes in alignment with program requirements.
Gene therapy workflows present filtration considerations tied to viral vector sensitivity, low product concentration, and scale-dependent variability, where small process changes can significantly influence recovery and purity. Filtration is applied during clarification to address cells, debris, and process-related impurities while preparing streams for downstream purification. Depth filtration, chromatographic clarification where applicable, and membrane-based approaches are integrated with downstream steps and assessed in the context of closed processing and scalability as programs move toward manufacturing.
Vaccine development and manufacturing require confident decisions that balance speed, quality, and performance as processes move from process development into commercial-scale production.
During harvest and early clarification, technologies such as the Harvest RC Chromatographic Clarifier platform are applied to help manage cells, debris, and process-related impurities. Zeta Plus depth filter capsules are used across clarification and downstream conditioning to address particulate and impurity burden.
These filtration approaches are evaluated alongside broader vaccine bioprocessing solutions to inform decisions as workflows are designed and scaled.
Plasma fractionation and purification involve complex feedstreams and multiple separation steps that require careful management of particulates and impurities across the process. Zeta Plus depth filters come in sheet, cartridge, and capsule formats. Zeta Plus depth filter capsules can fulfill depth filtration needs in an easy-to-use format.
Sterile membrane filtration is applied as part of plasma processing workflows to support microbiological control in highly regulated environments. LifeASSURE PDA filters come with advanced pleat technology to increase the effective filtration area with advanced pleat technology to increase the effective filtration area.
Chemical pharmaceutical manufacturing involves a wide range of chemistries and processing conditions that influence filtration requirements across multiple stages, including active pharmaceutical ingredient (API) manufacturing and sterile filtration. Membrane-based separations and depth filtration are applied for clarification, impurity reduction, and sterile filtration in alignment with process and regulatory needs.
Zeta Plus activated carbon filters and Zeta Plus SP depth filter are used to support clarification and impurity management, while LifeASSURE membrane filters are applied where membrane-based separations and sterile filtration are required. Filtration configurations are selected based on process requirements and facility design.
Intended use of the products mentioned on this page vary. For specific intended use statements, please refer to the Instructions for Use for the product.